February 9, 2018 / 6:46 AM / 9 months ago

BRIEF-PledPharma Updates On Pledox Phase I Study In Japan

Feb 9 (Reuters) - Pledpharma Ab (Publ):

* PLEDOX® SHOWS FAVORABLE SAFETY AND TOLERABILITY PROFILE IN THE SUNCIST PHASE I STUDY IN JAPANESE SUBJECTS

* ‍PLEDOX® SHOWS FAVORABLE SAFETY AND TOLERABILITY PROFILE IN SUNCIST PHASE I STUDY IN JAPANESE SUBJECTS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below